Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy

Edoardo Gronda, Stefano Genovese, Luigi Padeletti, Francesco Cacciatore, Dino Franco Vitale, Renato Bragato, Lisa Innocenti, Concetta Schiano, Linda Sommese, Maria Rosaria De Pascale, Luca Genovese, Pasquale Abete, Francesco Donatell, Claudio Napoli

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: The use of cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillator (ICD) for advanced heart failure (HF) is increasing. Renal dysfunction is a common condition in HF which is associated with a worse survival. The study aims at identifying in patients with advanced HF treated with CRT the effect of baseline glomerular filtration rate (GFR), GFR improvement and left ventricular ejection fraction (LVEF) change, after 6-months of CRT implant, on survival. Methods: The study population consisted of 375 advanced HF patients who received a CRT between 1999 and 2009, of these 277 received also an ICD implant. Clinical characteristics (New York Heart Association [NYHA] functional class, ischemic vs. non-ischemic etiology, atrial fibrillation, diabetes, hypertension, LVEF, QRS duration and GFR were recorded. The use of common used drugs was evaluated. Cox proportional hazards analysis was calculated in order to evaluate variables associated to mortality. Results: During a median follow-up of 43.0 months, 93 (24.8%) patients died. Patients deceased during the study had at baseline higher NYHA class and lower LVEF and GFR. In Cox regression analysis, GFR predicts long-term mortality (hazard ratio [HR] 0.983; 95% confidence interval [CI] 0.969–0.998; p = 0.023) independently from the effect of others covariates. In addition, a positive GFR improvement 6 months after CRT implant is significantly associated with a lower hazard of mortality (for each 10 mL/min of GFR improvement HR 0.86; 95% CI 0.75–0.99; p = 0.038). Conclusions: GFR is a significant predictor of mortality in advanced HF patients who received CRT. A GFR improvement 6 months after CRT implant is significantly associated with a lower hazard of mortality.

Original languageEnglish
Pages (from-to)459-466
Number of pages8
JournalCardiology Journal
Volume22
Issue number4
DOIs
Publication statusPublished - Aug 31 2015

Fingerprint

Glomerular Filtration Rate
Cardiac Resynchronization Therapy
Heart Failure
Kidney
Mortality
Stroke Volume
Therapeutics
Implantable Defibrillators
Confidence Intervals
Survival
Atrial Fibrillation
Regression Analysis
Hypertension
Pharmaceutical Preparations
Population

Keywords

  • Cardiac resynchronization therapy
  • Heart failure
  • Outcome
  • Renal function

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy. / Gronda, Edoardo; Genovese, Stefano; Padeletti, Luigi; Cacciatore, Francesco; Vitale, Dino Franco; Bragato, Renato; Innocenti, Lisa; Schiano, Concetta; Sommese, Linda; Pascale, Maria Rosaria De; Genovese, Luca; Abete, Pasquale; Donatell, Francesco; Napoli, Claudio.

In: Cardiology Journal, Vol. 22, No. 4, 31.08.2015, p. 459-466.

Research output: Contribution to journalArticle

Gronda, Edoardo ; Genovese, Stefano ; Padeletti, Luigi ; Cacciatore, Francesco ; Vitale, Dino Franco ; Bragato, Renato ; Innocenti, Lisa ; Schiano, Concetta ; Sommese, Linda ; Pascale, Maria Rosaria De ; Genovese, Luca ; Abete, Pasquale ; Donatell, Francesco ; Napoli, Claudio. / Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy. In: Cardiology Journal. 2015 ; Vol. 22, No. 4. pp. 459-466.
@article{803db2d673b34780b6a5301719bfb771,
title = "Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy",
abstract = "Background: The use of cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillator (ICD) for advanced heart failure (HF) is increasing. Renal dysfunction is a common condition in HF which is associated with a worse survival. The study aims at identifying in patients with advanced HF treated with CRT the effect of baseline glomerular filtration rate (GFR), GFR improvement and left ventricular ejection fraction (LVEF) change, after 6-months of CRT implant, on survival. Methods: The study population consisted of 375 advanced HF patients who received a CRT between 1999 and 2009, of these 277 received also an ICD implant. Clinical characteristics (New York Heart Association [NYHA] functional class, ischemic vs. non-ischemic etiology, atrial fibrillation, diabetes, hypertension, LVEF, QRS duration and GFR were recorded. The use of common used drugs was evaluated. Cox proportional hazards analysis was calculated in order to evaluate variables associated to mortality. Results: During a median follow-up of 43.0 months, 93 (24.8{\%}) patients died. Patients deceased during the study had at baseline higher NYHA class and lower LVEF and GFR. In Cox regression analysis, GFR predicts long-term mortality (hazard ratio [HR] 0.983; 95{\%} confidence interval [CI] 0.969–0.998; p = 0.023) independently from the effect of others covariates. In addition, a positive GFR improvement 6 months after CRT implant is significantly associated with a lower hazard of mortality (for each 10 mL/min of GFR improvement HR 0.86; 95{\%} CI 0.75–0.99; p = 0.038). Conclusions: GFR is a significant predictor of mortality in advanced HF patients who received CRT. A GFR improvement 6 months after CRT implant is significantly associated with a lower hazard of mortality.",
keywords = "Cardiac resynchronization therapy, Heart failure, Outcome, Renal function",
author = "Edoardo Gronda and Stefano Genovese and Luigi Padeletti and Francesco Cacciatore and Vitale, {Dino Franco} and Renato Bragato and Lisa Innocenti and Concetta Schiano and Linda Sommese and Pascale, {Maria Rosaria De} and Luca Genovese and Pasquale Abete and Francesco Donatell and Claudio Napoli",
year = "2015",
month = "8",
day = "31",
doi = "10.5603/CJ.a2015.0019",
language = "English",
volume = "22",
pages = "459--466",
journal = "Cardiology Journal",
issn = "1897-5593",
publisher = "Via Medica",
number = "4",

}

TY - JOUR

T1 - Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy

AU - Gronda, Edoardo

AU - Genovese, Stefano

AU - Padeletti, Luigi

AU - Cacciatore, Francesco

AU - Vitale, Dino Franco

AU - Bragato, Renato

AU - Innocenti, Lisa

AU - Schiano, Concetta

AU - Sommese, Linda

AU - Pascale, Maria Rosaria De

AU - Genovese, Luca

AU - Abete, Pasquale

AU - Donatell, Francesco

AU - Napoli, Claudio

PY - 2015/8/31

Y1 - 2015/8/31

N2 - Background: The use of cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillator (ICD) for advanced heart failure (HF) is increasing. Renal dysfunction is a common condition in HF which is associated with a worse survival. The study aims at identifying in patients with advanced HF treated with CRT the effect of baseline glomerular filtration rate (GFR), GFR improvement and left ventricular ejection fraction (LVEF) change, after 6-months of CRT implant, on survival. Methods: The study population consisted of 375 advanced HF patients who received a CRT between 1999 and 2009, of these 277 received also an ICD implant. Clinical characteristics (New York Heart Association [NYHA] functional class, ischemic vs. non-ischemic etiology, atrial fibrillation, diabetes, hypertension, LVEF, QRS duration and GFR were recorded. The use of common used drugs was evaluated. Cox proportional hazards analysis was calculated in order to evaluate variables associated to mortality. Results: During a median follow-up of 43.0 months, 93 (24.8%) patients died. Patients deceased during the study had at baseline higher NYHA class and lower LVEF and GFR. In Cox regression analysis, GFR predicts long-term mortality (hazard ratio [HR] 0.983; 95% confidence interval [CI] 0.969–0.998; p = 0.023) independently from the effect of others covariates. In addition, a positive GFR improvement 6 months after CRT implant is significantly associated with a lower hazard of mortality (for each 10 mL/min of GFR improvement HR 0.86; 95% CI 0.75–0.99; p = 0.038). Conclusions: GFR is a significant predictor of mortality in advanced HF patients who received CRT. A GFR improvement 6 months after CRT implant is significantly associated with a lower hazard of mortality.

AB - Background: The use of cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillator (ICD) for advanced heart failure (HF) is increasing. Renal dysfunction is a common condition in HF which is associated with a worse survival. The study aims at identifying in patients with advanced HF treated with CRT the effect of baseline glomerular filtration rate (GFR), GFR improvement and left ventricular ejection fraction (LVEF) change, after 6-months of CRT implant, on survival. Methods: The study population consisted of 375 advanced HF patients who received a CRT between 1999 and 2009, of these 277 received also an ICD implant. Clinical characteristics (New York Heart Association [NYHA] functional class, ischemic vs. non-ischemic etiology, atrial fibrillation, diabetes, hypertension, LVEF, QRS duration and GFR were recorded. The use of common used drugs was evaluated. Cox proportional hazards analysis was calculated in order to evaluate variables associated to mortality. Results: During a median follow-up of 43.0 months, 93 (24.8%) patients died. Patients deceased during the study had at baseline higher NYHA class and lower LVEF and GFR. In Cox regression analysis, GFR predicts long-term mortality (hazard ratio [HR] 0.983; 95% confidence interval [CI] 0.969–0.998; p = 0.023) independently from the effect of others covariates. In addition, a positive GFR improvement 6 months after CRT implant is significantly associated with a lower hazard of mortality (for each 10 mL/min of GFR improvement HR 0.86; 95% CI 0.75–0.99; p = 0.038). Conclusions: GFR is a significant predictor of mortality in advanced HF patients who received CRT. A GFR improvement 6 months after CRT implant is significantly associated with a lower hazard of mortality.

KW - Cardiac resynchronization therapy

KW - Heart failure

KW - Outcome

KW - Renal function

UR - http://www.scopus.com/inward/record.url?scp=84940558092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940558092&partnerID=8YFLogxK

U2 - 10.5603/CJ.a2015.0019

DO - 10.5603/CJ.a2015.0019

M3 - Article

C2 - 26325259

AN - SCOPUS:84940558092

VL - 22

SP - 459

EP - 466

JO - Cardiology Journal

JF - Cardiology Journal

SN - 1897-5593

IS - 4

ER -